Go Pro
NASDAQ:COCH

Envoy Medical Q2 2026 Earnings Report

Envoy Medical logo
$0.66 -0.02 (-3.01%)
Closing price 03:59 PM Eastern
Extended Trading
$0.66 0.00 (-0.09%)
As of 04:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Envoy Medical EPS Results

Actual EPS
-$0.07
Consensus EPS
-$0.08
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

Envoy Medical Revenue Results

Actual Revenue
$0.05 million
Expected Revenue
$0.05 million
Beat/Miss
Beat by +$1.00 thousand
YoY Revenue Growth
N/A

Envoy Medical Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Monday, August 10, 2026
Conference Call Time
7:00AM ET

Upcoming Earnings

Envoy Medical's Q3 2026 earnings is estimated for Monday, November 9, 2026, based on past reporting schedules, with a conference call scheduled on Tuesday, November 10, 2026 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Envoy Medical Earnings Headlines

ENVOY MEDICAL INC 0,691 +2,92 %
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel
See More Envoy Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Envoy Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Envoy Medical and other key companies, straight to your email.

About Envoy Medical

Envoy Medical (NASDAQ:COCH) is a medical device company focused on developing implantable solutions for people with hearing loss. The company’s technology is designed to provide an alternative to conventional hearing aids and other externally worn hearing devices by using an implanted system to capture and process sound.

Envoy Medical’s principal product is the Acclaim fully implanted active middle ear implant. The device is designed to be implanted beneath the skin and use the body’s natural anatomy to help transmit sound to the inner ear. The company has also developed other implantable hearing technologies and maintains a focus on improving hearing access, convenience and quality of life for patients.

Founded in 1995, Envoy Medical is headquartered in White Bear Lake, Minnesota. Its products are intended for the global hearing-loss market, subject to applicable regulatory approvals. The company is led by Chief Executive Officer Brent Lucas and became a publicly traded company through a business combination with Anzu Special Acquisition Corp I in 2023.

View Envoy Medical Profile